BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 18, 2011
View Archived Issues
Neramexane mesilate is safe and well tolerated in subjects with tinnitus
Read More
RBC-mimicking hydrogel microparticles display improved biodistribution and circulation times
Read More
VKORC1 gene variations are associated with bone mineral density
Read More
MMRF and Synta Pharma to codevelop ganetespib for multiple myeloma
Read More
Lorus Therapeutics begins phase I trial of anticancer candidate LOR-253
Read More
Colesevelam has beneficial effects in patients with type 1 diabetes
Read More
Microtubule-associated protein 2 as a biomarker for traumatic brain injury
Read More
Bikam Pharmaceuticals presents new opsin ligands
Read More
New inhibitors of osteoclast differentiation/stimulation claimed
Read More
Vaximm obtains funding for phase I testing of VXM-01 vaccine
Read More
GSK patents new inhibitors of serotonin, dopamine and norepinephrine reuptake
Read More
Lilly and Boehringer Ingelheim enter global diabetes alliance
Read More
FDA agrees to SPA for phase III trials of netupitant/palonosetron as antiemetic
Read More
Epizyme and GSK join to develop agents targeting histone methyltransferases
Read More
GSK develops novel lysophospholipid S1P1 receptor agonists
Read More
Discovery Labs to prepare complete response to gain FDA approval for Surfaxin
Read More
Galapagos provides update on arthritis alliance with GSK
Read More
FDA approves new formulation of acetylcysteine injection
Read More
Risk of severe liver injury to be added to Multaq labels
Read More
Phase I trial to evaluate hydroxychloroquine to block autophagy in cancer
Read More
Phase I/II trial of Mologen's MGN-1601 in renal cancer cleared to admit all patients
Read More
Merck Serono and Domain Therapeutics join to develop agents for Parkinson's disease
Read More
Phase II trial of ADXS-11-001 in cervical dysplasia advances
Read More
Health Canada requests more information from Osiris regarding Prochymal approval
Read More
Bayer and Regeneron initiate phase III Asian trial of VEGF Trap-Eye
Read More